U07.1
Conditions
Interventions
Group 1: 5-10ml of the exahaltion of SARS-CoV2 infected as well as of patients suffering from COVID-19 are collected from the oral portion of the exhalation as well as from the nasal part
the probes are analyzed with the BreathSpec®, a specifically designed gas chromatography
the exhalation of healthy test persons, negatively tested for the SARS-CoV2, will be taken as controls
Sponsors
Klinik für Neurochirurgie Klinikum Dortmund
Eligibility
Sex/Gender
All
Age
1 Years to 99 Years
Inclusion criteria
Inclusion criteria: test persons are lung healthy volunteers employed at the Klinikum Dortmund; due to the quarantaine zone it will not be possible to include non-employees SARS-CoV2 infected patients and patients suffering from COVID-19, tested and treated at the Klinikum Dortmund, will be asked for participation irrespective of age and gender
Exclusion criteria
Exclusion criteria: test persons with a proven infection with SARS-CoV2, even though the infection might be dected >14d before, cannot be included; test persons and patients with any proven infection of the respiratory tract within 4 weeks aside from SARS-CoV2, neoplasia or chronic respiratory or pulmonary illnesses are excluded. test persons or patients in need of inhalative medication or medication targeted on the lung or respiratory tract are excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| identification of a characteristic index of SARS-CoV2 in the gas chromatography / ionic motility spectrometer | — |
Secondary
| Measure | Time frame |
|---|---|
| quantitative assessment of the viral load at different points during the course of the infection with SARS-CoV2 a) patients infected without signs of COVID-19 b) patient suffering from COVID-19 | — |
Countries
Germany
Contacts
Public ContactOliver Müller
Klinik für Neurochirurgie Klinikum Dortmund
Outcome results
None listed